Sickle cell disease in Africa: an urgent need for longitudinal cohort studies

The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort study

A report on sickle cell in Sierra Leone

Greater number of perceived barriers to hydroxyurea associated with poorer health‐related quality of life in youth with sickle cell disease

Improving Care for Sickle Cell Pain Crisis Using a Multidisciplinary Approach

Effect of Sickle Cell Anemia Therapies on the Natural History of Growth and Puberty Patterns

Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease

Cardiovascular manifestatoins of sickle cell disease

Lessons Learned from Building a Pediatric-to-Adult Sickle Cell Transition Program

Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature

Pain and sickle cell disease

Nutritional Status, Nutrient Intake, and Food Diversity Among Children With Sickle Cell Anemia

Hydroxyurea use among children with sickle cell anemia

Implementation of an educational intervention to optimize self-management and transition readiness in young adults with sickle cell disease

Hydroxyurea use in young infants with sickle cell disease

Overcoming challenges of venous thromboembolism in sickle cell disease treatment

HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges

Social-environmental factors and cognitive and behavioral functioning in pediatric sickle cell disease

Hydroxyurea – An Essential Medicine for Sickle Cell Disease in Africa

Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease

Resolving inflammation and pain of sickle cel.

New Therapeutic Options for the Treatment of Sickle Cell Disease

Gene Therapy for Sickle Cell Disease Shows Promise

Pediatric pain screening identifies youth at risk of chronic pain in sickle cell disease

Multidisciplinary care results in similar maternal and perinatal mortality rates for women with and without SCD in a low-resource setting

Risk of avascular necrosis of the femoral head in children with sickle cell disease on hydroxyurea: MRI evaluation

How I manage hypoxia in adults with hemoglobinopathies and hemolytic disorders

How I treat the older adult with sickle cell disease.

Hydroxyurea for Children with Sickle Cell Anemia in sub-Saharan Africa

Resistance to Plasmodium falciparum in sickle cell trait erythrocytes is driven by oxygen-dependent growth inhibition

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia

Hydroxyurea for SCA in Africa: no malaria harm